465 results on '"Rosen, Mitchell P"'
Search Results
2. Hormone concentrations of dominant follicles in the TALES randomized controlled trial comparing letrozole with tamoxifen.
3. Breast cancer grade and stage do not affect fertility preservation outcomes
4. Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial
5. Conception after chemotherapy: post-chemotherapy method of conception and pregnancy outcomes in breast cancer patients
6. Fertility preservation practices for female oncofertility differ significantly across the USA: results of a survey of SREI members
7. Back-to-back random-start ovarian stimulation prior to chemotherapy to maximize oocyte yield.
8. QOLP-24. ATTITUDES TOWARD FERTILITY AND FERTILITY PRESERVATION IN WOMEN WITH GLIOMA
9. A deep dive into the morphokinetics and ploidy of low-quality blastocysts
10. Antral follicle count recovery in women with menses after treatment with and without gonadotropin-releasing hormone agonist use during chemotherapy for breast cancer
11. Decreased clinical pregnancy and live birth rates after short interval from delivery to subsequent assisted reproductive treatment cycle
12. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
13. Author Correction: A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols
14. ATTITUDES TOWARD FERTILITY AND FERTILITY PRESERVATION IN WOMEN WITH GLIOMA
15. Diminished ovarian reserve is associated with reduced euploid rates via preimplantation genetic testing for aneuploidy independently from age: evidence for concomitant reduction in oocyte quality with quantity
16. Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield
17. Regret around fertility choices is decreased with pre-treatment counseling in gynecologic cancer patients
18. Testicular niche required for human spermatogonial stem cell expansion.
19. A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders
20. Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling women
21. Does accelerated reproductive aging underlie premenopausal risk for cardiovascular disease?
22. Disruptions in ovarian function are related to depression and cardiometabolic risk during premenopause
23. Comparison of age at natural menopause in BRCA1/2 mutation carriers with a non–clinic‐based sample of women in northern California
24. Ovarian stimulation and egg retrieval in the acutely ill patient: special considerations
25. Depressive symptomatology, psychological stress, and ovarian reserve: a role for psychological factors in ovarian aging?
26. Genetic markers of ovarian follicle number and menopause in women of multiple ethnicities
27. Decision-making surrounding the use of preimplantation genetic testing for aneuploidy reveals misunderstanding regarding its benefit
28. Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women.
29. The effect of follicular fluid hormones on oocyte recovery after ovarian stimulation: FSH level predicts oocyte recovery
30. Presence of Fibroids on Transvaginal Ultrasonography in a Community-Based, Diverse Cohort of 996 Reproductive-Age Female Participants
31. Controlled Ovarian Stimulation Protocols in Cancer Patients
32. Sexual satisfaction and quality of life in survivors of localized cervical and ovarian cancers following fertility-sparing surgery
33. Fertility preservation with ovarian stimulation and time to treatment in women with stage II–III breast cancer receiving neoadjuvant therapy
34. Selecting and Screening Recipients: Diminished Ovarian Reserve and Premature Ovarian Failure
35. FIBROID PREVALENCE AND BURDEN BY RACE IN AN ASYMPTOMATIC, DIVERSE COHORT OF REPRODUCTIVE-AGE WOMEN
36. ANXIETY AND DISTRESS IN YOUNG NEWLY DIAGNOSED CANCER PATIENTS DECREASE AFTER A FERTILITY PRESERVATION CONSULT
37. Fertility Preservation Services for Women With Newly Diagnosed Cancer: A National Assessment
38. Interpregnancy Interval and Singleton Live Birth Outcomes From In Vitro Fertilization
39. Women with polycystic ovary syndrome demonstrate worsening markers of cardiovascular risk over the short‐term despite declining hyperandrogenaemia: Results of a longitudinal study with community controls
40. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation
41. Microfluidic preparation of spermatozoa for ICSI produces similar embryo quality to density-gradient centrifugation: a pragmatic, randomized controlled trial
42. Ovarian stimulation in cancer patients
43. Response to ovarian stimulation is not impacted by a breast cancer diagnosis
44. Aneuploidy rates and morphokinetic parameters of embryos cultured in distinct culture media: a sibling oocyte study
45. Current Clinical Approaches to Protecting the Ovary
46. List of Contributors
47. Fertilization rate is an independent predictor of implantation rate
48. Follicular fluid steroid hormone levels are associated with fertilization outcome after intracytoplasmic sperm injection
49. A MACHINE LEARNING ALGORITHM CAN OPTIMIZE THE DAY OF TRIGGER TO IMPROVE IN VITRO FERTILIZATION OUTCOMES
50. CHARACTERISTICS OF FOLLICULAR FLUID IN THE TALES RANDOMIZED CONTROLLED TRIAL
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.